Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia

Clinical Biochemistry

Volumn 36, Issue 3, 2003, Pages 221-223

  Altinkaynak, Konca ^a   Aksoy, Hülya ^a   Bakan, Ebubekir ^a   Kumtepe, Yakup ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

IGF I; IGF I IGFBP 3; Preeclampsia

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MATERNAL SERUM; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0037406392     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(03)00008-0     Document Type: Article

References (18)

1. Dekker G.A., Sibai B.H. Early detection of preeclampsia. Am J Obstet Gynecol. 165:1991;160-172.
2. Jones J.L., Clemmons D.R. Insulin-like growth factors and their binding proteins biological actions . Endocr Rev. 16:1995;3-34.
3. Chard T. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul. 4:(3):1994;91-100.
4. Halhali A., Bourges H., Carrillo A., Garabedian M. Lower circulating insulin-like growth factor I and 1,25-dihydroxyvitamin D levels in preeclampsia. Rev Invest Clin. 47:(4):1995;259-266.
5. Giudice L.C., Martina N.A., Crystal R.A., Tazuke S., Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol. 176:(4):1997;751-757.
6. Rosenfeld R.G., Hwa V., Wilson L., et al. The insulin-like growth factor binding protein superfamily new perspectives . Pediatrics. 104:(4 Pt 2):1999;1018-1021.
7. Binoux M., Hossenlopp P. IGF, and IGFBPs comparison of human serum, and lymph . J Clin Endocrinol Metab. 67:1988;509-514.
8. Wang H.S., Lee J.D., Cheng B.J., Soong Y.K. Insulin-like growth factor-binding protein 1 and insulin-like growth factor-binding protein 3 in pre-eclampsia. Br J Obstet Gynecol. 103:(7):1996;654-659.
9. Davey D.A., MavGilliray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 158:1988;892.
10. Baxter R.C., Cowell C.T. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab. 65:(3):1987;432-440.
11. Wallenstein S., Zucker C.L., Fleis J.L. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.
12. Lopez-Jaramillo P., Casas J.P., Serrano N. Preeclampsia from epidemiological observations to molecular mechanisms . Braz J Med Biol Res. 34:(10):2001;1227-1235.
13. Halhali A., Toyar A.R., Torres N., Bourges H., Garabedian M., Larrea F. Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25 dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab. 85:(5):2000;1828-1833.
14. Giudice L.C., Farrell E.M., Pham H., Lamson G., Rosenfeld R.G. Insulin-like growth factors binding proteins in maternal serum throughout gestation and in the puerperium effects of a pregnancy associated serum protease activity . J Clin Endocrinol Metab. 71:(4):1990;806-816.
15. Bartha J.L., Romero-Carmona R., Torrejon-Cardoso R., Comino-Delgado R. Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol. 187:(3):2002;735-740. Sep.
16. Sowers M., Scholl T., Grewal J., Chen X., Jannausch M. IGF-I, osteocalcin, and bone change in pregnant normotensive, and pre-eclamptic women. J Clin Endocrinol Metab. 86:(12):2001;5898-5903.
17. Varma M., de Groot C.J., Lanyi S., Taylor R.N. Evaluation of plasma insulin-like growth factor-binding protein-3 as a potential predictor of preeclampsia. Am J Obstet Gynecol. 169:(4):1993;995-999.
18. Juul A., Main K., Blum W.F., Lindholm J., Ranke M.B., Skakkebaek N.E. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf). 41:(1):1994;85-93.